Drug: infliximab Quarter: 2016Q3
Total Drug/Injury Combinations: 643 Number of Pages: 33
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| INFLIXIMAB | Pulmonary mass | 3 | view events |
| INFLIXIMAB | Rheumatoid arthritis | 3 | view events |
| INFLIXIMAB | Rotavirus infection | 3 | view events |
| INFLIXIMAB | Tenosynovitis | 3 | view events |
| INFLIXIMAB | Therapeutic response decreased | 3 | view events |
| INFLIXIMAB | Tonsillitis | 3 | view events |
| Infliximab BS for I.V. Infusion100 (CTH) | Anaemia | 3 | view events |
| Infliximab BS for I.V. Infusion100 (CTH) | Delirium | 3 | view events |
| Infliximab BS for I.V. Infusion100 (CTH) | Device related infection | 3 | view events |
| Infliximab BS for I.V. Infusion100 (CTH) | Embolism arterial | 3 | view events |
| Infliximab BS for I.V. Infusion100 (CTH) | Jugular vein thrombosis | 3 | view events |
| Infliximab BS for I.V. Infusion100 (CTH) | Platelet count increased | 3 | view events |
| INFLIXIMAB HOSPIRA | Activities of daily living impaired | 3 | view events |
| INFLIXIMAB HOSPIRA | Drug hypersensitivity | 3 | view events |
| INFLIXIMAB HOSPIRA | Headache | 3 | view events |
| INFLIXIMAB HOSPIRA | Lupus-like syndrome | 3 | view events |
| INFLIXIMAB HOSPIRA | Red blood cell sedimentation rate increased | 3 | view events |
| INFLIXIMAB HOSPIRA | Synovitis | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Anaphylactoid reaction | 3 | view events |
| INFLIXIMAB, RECOMBINANT | Atypical fibroxanthoma | 3 | view events |
Total Drug/Injury Combinations: 643 Number of Pages: 33
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)